Basilea Pharmaceutica AG

SWX:BSLN Stock Report

Market Cap: CHF 487.9m

Basilea Pharmaceutica Balance Sheet Health

Financial Health criteria checks 5/6

Basilea Pharmaceutica has a total shareholder equity of CHF16.8M and total debt of CHF95.7M, which brings its debt-to-equity ratio to 570%. Its total assets and total liabilities are CHF188.7M and CHF171.9M respectively.

Key information

570.0%

Debt to equity ratio

CHF 95.68m

Debt

Interest coverage ration/a
CashCHF 62.96m
EquityCHF 16.79m
Total liabilitiesCHF 171.88m
Total assetsCHF 188.66m

Recent financial health updates

No updates

Recent updates

Shareholders May Be More Conservative With Basilea Pharmaceutica AG's (VTX:BSLN) CEO Compensation For Now

Apr 18
Shareholders May Be More Conservative With Basilea Pharmaceutica AG's (VTX:BSLN) CEO Compensation For Now

Does Basilea Pharmaceutica (VTX:BSLN) Deserve A Spot On Your Watchlist?

Sep 20
Does Basilea Pharmaceutica (VTX:BSLN) Deserve A Spot On Your Watchlist?

Robust Earnings May Not Tell The Whole Story For Basilea Pharmaceutica (VTX:BSLN)

Feb 17
Robust Earnings May Not Tell The Whole Story For Basilea Pharmaceutica (VTX:BSLN)

Revenue Downgrade: Here's What Analysts Forecast For Basilea Pharmaceutica AG (VTX:BSLN)

Jul 01
Revenue Downgrade: Here's What Analysts Forecast For Basilea Pharmaceutica AG (VTX:BSLN)

Analysts Expect Breakeven For Basilea Pharmaceutica AG (VTX:BSLN) Before Long

Mar 24
Analysts Expect Breakeven For Basilea Pharmaceutica AG (VTX:BSLN) Before Long

If You Had Bought Basilea Pharmaceutica's (VTX:BSLN) Shares Three Years Ago You Would Be Down 19%

Feb 18
If You Had Bought Basilea Pharmaceutica's (VTX:BSLN) Shares Three Years Ago You Would Be Down 19%

Financial Position Analysis

Short Term Liabilities: BSLN's short term assets (CHF155.0M) exceed its short term liabilities (CHF37.8M).

Long Term Liabilities: BSLN's short term assets (CHF155.0M) exceed its long term liabilities (CHF134.1M).


Debt to Equity History and Analysis

Debt Level: BSLN's net debt to equity ratio (194.9%) is considered high.

Reducing Debt: BSLN had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable BSLN has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: BSLN is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 40.5% per year.


Discover healthy companies